ANGELA HAMILTON: Open Payments
NPI 1215470489 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 91 payments from 14 companies in 2025. Trend: 2023 $1,437 · 2024 $1,084 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $352 |
| Ardelyx, Inc. | 11 | $146 |
| Janssen Biotech, Inc. | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| GENZYME CORPORATION | 5 | $119 |
| Gilead Sciences, Inc. | 6 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Celltrion USA Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 4 | $34 |
| Madrigal Pharmaceuticals | 2 | $33 |
Products named: IBSRELA, RINVOQ, TREMFYA, CREON, DUPIXENT, ENTYVIO, XIFAXAN, SKYRIZI.
Industry payments across TN — which companies pay providers there.
